mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.05 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.05 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |